SynthesisDeutsches Arzteblatt international2010

The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.

Gisela Schott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.